Variable | Total1(n = 207) | Stage I/II1(n = 64) | Stage III1(n = 81) | Stage IV/V1(n = 62) | P-value |
---|---|---|---|---|---|
Age (years) | 61.43 ± 12.03 | 56.64 ± 11.65 | 62.78 ± 11.53a | 64.61 ± 11.72a | <0.001* |
Sex | 0.177 | ||||
Males | 119 (57.5) | 34 (53.1) | 53 (65.4) | 32 (51.6) | |
Females | 88 (42.5) | 30 (46.9) | 28 (34.6) | 30 (48.4) | |
BMI (kg/m2) | 23.42 (21.45 , 25.83) | 23.54 (21.32 , 25.77) | 22.86 (21.16 , 25.52) | 24.05 (22.04 , 25.92) | 0.262 |
BSA (m2) | 1.66 (1.54 , 1.80) | 1.66 (1.52 , 1.77) | 1.64 (1.54 , 1.81) | 1.69 (1.54 , 1.77) | 0.826 |
Alb (g/dL) | 3.75 (3.19 , 4.20) | 4.00 (3.51 , 4.41) | 3.83 (3.30 , 4.18) | 3.39 (2.99 , 3.84)ab | <0.001* |
SCr (mg/dL) | 1.52 (0.92 , 3.72) | 0.77 (0.57 , 1.09) | 1.58 (1.09 , 2.39) a | 5.19 (2.99 , 7.01)ab | <0.001* |
BUN (mg/dL) | 27.17 (17.76 , 48.54) | 16.70 (13.74 , 21.25) | 27.90 (18.74 , 44.82)a | 54.68 (41.29 , 70.60)ab | <0.001* |
DTPA-GFR (mL/min/1.73 m2) | 43.45 (25.35 , 64.36) | 78.39 (66.86 , 87.89) | 43.42 (35.81 , 54.82) a | 19.70 (14.58 , 23.19)ab | <0.001* |
GFR ≧60 mL/min/1.73 m2 | 64 (30.9) | 64 (100) | 0 (0) | 0 (0) | |
GFR <60 mL/min/1.73 m2 | 143 (69.1) | 0 (0) | 81 (100) | 62 (100) |